Search Results 6321-6330 of 25575 for oral
* Treatment with oral cyclophosphamide within 1 year prior to baseline Treatment with any investigational drug (including bortezomib) within 24 weeks prior ...
After undergoing robotic surgery, radiation therapy and chemotherapy as part of a clinical trial to treat cancer, Bruce Trulson has gained a new understanding ...
Paschalis Vergidis, M.D.. Closed for enrollment. More information. Publications. Ibrexafungerp: A novel oral glucan synthase inhibitor. Davis MR. M R; Donnelley ...
Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology/Oncology · Pediatric Otolaryngology · Pediatrics · Physical ...
... oral tyrosine kinase inhibitors, eg, imatinib or nilotinib, are allowed. Active cancer (either concurrent or within the last year of starting study ...
2024. Kincaid CM, Sharma AN, Sargent B, Gradus-Pizlo I, Dineen EH, Mesinkovska NA. Evaluation of Pericardial Effusions in Alopecia Patients on Low-Dose Oral ...
... oral cavity, cervix, melanoma in situ, or other non-invasive malignancies are permissible); Previous radiotherapy to the scalp, cranium, brain, or skull base ...
Dr. Bauer: “They've become so popular. Like so many dietary supplements, patients are looking for something to help their health, so they're reading about over- ...
... Oral Word Association (COWA) test, and the Trail Making Test (TMT). Participation eligibility. Participant eligibility includes age, gender, type and stage ...
... Oral and throat cancer, Adenocarcinoma, Laryngeal cancer, Carotid body tumor, Tongue base cancer, Mouth tumor, Salivary gland cancer, Parotid cancer ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.